{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:28:26Z","timestamp":1767770906725},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:00:00Z","timestamp":1362528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00428-013-1388-2","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T07:11:21Z","timestamp":1362467481000},"page":"445-453","source":"Crossref","is-referenced-by-count":17,"title":["Low RKIP expression associates with poor prognosis in bladder cancer patients"],"prefix":"10.1007","volume":"462","author":[{"given":"Julieta","family":"Afonso","sequence":"first","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Martinho","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Lobo","sequence":"additional","affiliation":[]},{"given":"Teresina","family":"Amaro","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"L\u00facio L.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"1388_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239\u2013249","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1388_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.urology.2006.10.041","volume":"69","author":"CN Sternberg","year":"2007","unstructured":"Sternberg CN, Donat SM, Bellmunt J et al (2007) Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 69(Suppl 1):62\u201379","journal-title":"Urology"},{"issue":"Suppl 10","key":"1388_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/annonc\/mdl231","volume":"17","author":"CN Sternberg","year":"2006","unstructured":"Sternberg CN (2006) Muscle invasive and metastatic bladder cancer. Ann Oncol 17(Suppl 10):23\u201330","journal-title":"Ann Oncol"},{"key":"1388_CR4","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279\u20133290","journal-title":"Oncogene"},{"key":"1388_CR5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"issue":"Suppl 1","key":"1388_CR6","first-page":"137","volume":"11","author":"R Stoehr","year":"2004","unstructured":"Stoehr R, Brinkmann A, Filbeck T et al (2004) No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract. Oncol Rep 11(Suppl 1):137\u2013141","journal-title":"Oncol Rep"},{"issue":"Suppl 1","key":"1388_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5301\/JBM.2009.4457","volume":"24","author":"I Boulalas","year":"2009","unstructured":"Boulalas I, Zaravinos A, Delakas D, Spandidos DA (2009) Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder. Int J Biol Markers 24(Suppl 1):17\u201321","journal-title":"Int J Biol Markers"},{"issue":"Suppl 4","key":"1388_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00313020902885011","volume":"41","author":"M Karlou","year":"2009","unstructured":"Karlou M, Saetta AA, Korkolopoulou P et al (2009) Activation of extracellular regulated kinases (ERK1\/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations. Pathology 41(Suppl 4):327\u2013334","journal-title":"Pathology"},{"key":"1388_CR9","doi-asserted-by":"crossref","unstructured":"Zaravinos A, Chatziioannou M, Lambrou GI et al (2011) Implication of RAF and RKIP genes in urinary bladder cancer. Pathol Oncol Res 17(Suppl2): 181\u2013190","DOI":"10.1007\/s12253-010-9295-1"},{"key":"1388_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2007.07.003","volume":"20","author":"J Klysik","year":"2008","unstructured":"Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K (2008) Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20:1\u20139","journal-title":"Cell Signal"},{"issue":"1","key":"1388_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000236595","volume":"32","author":"J Hellmann","year":"2010","unstructured":"Hellmann J, Rommelspacher H, M\u00fchlbauer E, Wernicke C (2010) Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells. Dev Neurosci 32(1):33\u201346","journal-title":"Dev Neurosci"},{"issue":"4","key":"1388_CR12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.molcel.2006.07.015","volume":"23","author":"EM Eves","year":"2006","unstructured":"Eves EM, Shapiro P, Naik K et al (2006) Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 23(4):561\u2013574","journal-title":"Mol Cell"},{"issue":"3","key":"1388_CR13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1039\/C0MB00208A","volume":"7","author":"F Al-Mulla","year":"2011","unstructured":"Al-Mulla F, Bitar MS, Taqi Z, Rath O, Kolch W (2011) RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. Mol Biosyst 7(3):928\u2013941","journal-title":"Mol Biosyst"},{"key":"1388_CR14","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/MCB.21.21.7207-7217.2001","volume":"21","author":"KC Yeung","year":"2001","unstructured":"Yeung KC, Rose DW, Dhillon AS et al (2001) Raf kinase inhibitor protein interacts witw NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21:7207\u20137217","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1388_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4014\/jmb.1012.12023","volume":"21","author":"SY Kim","year":"2011","unstructured":"Kim SY, Park SG, Jung H et al (2011) RKIP downregulation induces the HBx-mediated Raf-1 mitochondrial translocation. J Microbiol Biotechnol 21(5):525\u2013528","journal-title":"J Microbiol Biotechnol"},{"issue":"40","key":"1388_CR16","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1038\/onc.2009.214","volume":"28","author":"S Baritaki","year":"2009","unstructured":"Baritaki S, Chapman A, Yeung K et al (2009) Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 28(40):3573\u20133485","journal-title":"Oncogene"},{"issue":"3","key":"1388_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1615\/CritRevImmunol.v29.i3.40","volume":"29","author":"K Wu","year":"2009","unstructured":"Wu K, Bonavida B (2009) The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29(3):241\u2013254","journal-title":"Crit Rev Immunol"},{"issue":"9","key":"1388_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2005.07.007","volume":"12","author":"S Zhu","year":"2005","unstructured":"Zhu S, Mc Henry KT, Lane WS, Fenteany G (2005) A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration. Chem Biol 12(9):981\u2013991","journal-title":"Chem Biol"},{"issue":"9","key":"1388_CR19","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/MCB.20.9.3079-3085.2000","volume":"20","author":"K Yeung","year":"2000","unstructured":"Yeung K, Janosch P, McFerran B et al (2000) Mechanism of suppression of the Raf\/MEK\/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 20(9):3079\u20133085","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1388_CR20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.febslet.2009.12.051","volume":"584","author":"H Tang","year":"2010","unstructured":"Tang H, Park S, Sun SC et al (2010) RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett 584(4):662\u2013668","journal-title":"FEBS Lett"},{"key":"1388_CR21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature02158","volume":"426","author":"K Lorenz","year":"2003","unstructured":"Lorenz K, Lohse MJ, Quitterer U et al (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426:574\u2013579","journal-title":"Nature"},{"issue":"4","key":"1388_CR22","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1158\/0008-5472.CAN-10-3102","volume":"71","author":"F Al-Mulla","year":"2011","unstructured":"Al-Mulla F, Bitar MS, Al-Maghrebi M et al (2011) Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3\u03b2. Cancer Res 71(4):1334\u20131343","journal-title":"Cancer Res"},{"key":"1388_CR23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/95.12.878","volume":"95","author":"Z Fu","year":"2003","unstructured":"Fu Z, Smith PC, Zhang L (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878\u2013879","journal-title":"J Natl Cancer Inst"},{"key":"1388_CR24","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1158\/1078-0432.CCR-05-0283","volume":"11","author":"S Hagan","year":"2005","unstructured":"Hagan S, Al-Mulla F, Mallon E (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392\u20137397","journal-title":"Clin Cancer Res"},{"key":"1388_CR25","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1200\/JCO.2006.07.5499","volume":"24","author":"F Al-Mulla","year":"2006","unstructured":"Al-Mulla F, Hagan S, Behbehani AI (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24:5672\u20135679","journal-title":"J Clin Oncol"},{"key":"1388_CR26","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1158\/0008-5472.CAN-03-3861","volume":"64","author":"MM Schuierer","year":"2004","unstructured":"Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK (2004) Reduction of Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 64:5186\u20135192","journal-title":"Cancer Res"},{"key":"1388_CR27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2559.2009.03425.x","volume":"55","author":"J Afonso","year":"2009","unstructured":"Afonso J, Santos LL, Amaro T, Lobo F, Longatto-Filho A (2009) The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion\u2014the prognostic contribution of related molecular markers. Histopathology 55:514\u2013524","journal-title":"Histopathology"},{"key":"1388_CR28","volume-title":"Urinary bladder cancer protocols and checklists","author":"MB Amin","year":"2005","unstructured":"Amin MB, Srigley JR, Grignon DJ et al (2005) Urinary bladder cancer protocols and checklists. College of American Pathologists, Northfield"},{"key":"1388_CR29","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York"},{"key":"1388_CR30","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-59871-5","volume-title":"World Health Organization, International Histological Classification of Tumours. Histological typing of urinary bladder tumours","author":"CJ Mostofi","year":"1999","unstructured":"Mostofi CJ, Davis CJ, Sesterhenn IA (1999) World Health Organization, International Histological Classification of Tumours. Histological typing of urinary bladder tumours. Springer, Berlin"},{"key":"1388_CR31","volume-title":"World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organ","author":"JN Eble","year":"2004","unstructured":"Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organ. IARC Press, Lyon"},{"issue":"Suppl 3","key":"1388_CR32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00428-009-0821-z","volume":"455","author":"O Martinho","year":"2009","unstructured":"Martinho O, Gouveia A, Silva P et al (2009) Loss of RKIP expression is associated with poor survival in GISTs. Virchows Arch 455(Suppl 3):277\u2013284","journal-title":"Virchows Arch"},{"issue":"Suppl 2","key":"1388_CR33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/jclinpath-2011-200358","volume":"65","author":"O Martinho","year":"2012","unstructured":"Martinho O, Faloppa CC, Neto CS et al (2012) Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. J Clin Pathol 65(Suppl 2):122\u2013128","journal-title":"J Clin Pathol"},{"issue":"1","key":"1388_CR34","doi-asserted-by":"crossref","first-page":"e30769","DOI":"10.1371\/journal.pone.0030769","volume":"7","author":"O Martinho","year":"2012","unstructured":"Martinho O, Granja S, Jaraquemada T et al (2012) Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One 7(1):e30769","journal-title":"PLoS One"},{"key":"1388_CR35","doi-asserted-by":"crossref","first-page":"124704","DOI":"10.1155\/2012\/124704","volume":"2012","author":"E Bevilacqua","year":"2012","unstructured":"Bevilacqua E, Frankenberger CA, Rosner MR (2012) RKIP suppresses breast cancer metastasis to the bone by regulating stroma-associated genes. Int J Breast Cancer 2012:124704","journal-title":"Int J Breast Cancer"},{"issue":"Suppl 4","key":"1388_CR36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s13277-012-0358-7","volume":"33","author":"C Hao","year":"2012","unstructured":"Hao C, Wei S, Tong Z et al (2012) The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro. Tumour Biol 33(Suppl 4):1159\u20131167","journal-title":"Tumour Biol"},{"issue":"Suppl 6","key":"1388_CR37","first-page":"1004","volume":"45","author":"H Xinzhou","year":"2011","unstructured":"Xinzhou H, Ning Y, Ou W et al (2011) RKIP inhibits the migration and invasion of human prostate cancer PC-3\u00a0M cells through regulation of extracellular matrix. Mol Biol (Mosk) 45(Suppl 6):1004\u20131011","journal-title":"Mol Biol (Mosk)"},{"issue":"Suppl 2","key":"1388_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2010.08.012","volume":"299","author":"AB Beshir","year":"2010","unstructured":"Beshir AB, Ren G, Magpusao AN et al (2010) Raf kinase inhibitor protein suppresses nuclear factor-\u03baB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett 299(Suppl 2):137\u2013149","journal-title":"Cancer Lett"},{"issue":"Suppl 15","key":"1388_CR39","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.onc.1210860","volume":"27","author":"S Beach","year":"2008","unstructured":"Beach S, Tang H, Park S et al (2008) Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 27(Suppl 15):2243\u20132248","journal-title":"Oncogene"},{"issue":"2","key":"1388_CR40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1083\/jcb.200512110","volume":"174","author":"S Thuault","year":"2006","unstructured":"Thuault S, Valcourt U, Petersen M et al (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial\u2013mesenchymal transition. J Cell Biol 174(2):175\u2013183","journal-title":"J Cell Biol"},{"issue":"9","key":"1388_CR41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.1540407","volume":"21","author":"YS Lee","year":"2007","unstructured":"Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21(9):1025\u20131030","journal-title":"Genes Dev"},{"issue":"4","key":"1388_CR42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/emboj.2008.294","volume":"28","author":"S Dangi-Garimella","year":"2009","unstructured":"Dangi-Garimella S, Yun J, Eves EM et al (2009) Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 28(4):347\u2013358","journal-title":"EMBO J"},{"issue":"21","key":"1388_CR43","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1038\/emboj.2011.312","volume":"30","author":"J Yun","year":"2011","unstructured":"Yun J, Frankenberger CA, Kuo WL et al (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30(21):4500\u20134514","journal-title":"EMBO J"},{"key":"1388_CR44","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.surg.2003.12.013","volume":"136","author":"L Zhang","year":"2004","unstructured":"Zhang L, Fu Z, Binkley C et al (2004) Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery 136:708\u2013715","journal-title":"Surgery"},{"issue":"Suppl 6","key":"1388_CR45","first-page":"917","volume":"6","author":"HZ Li","year":"2008","unstructured":"Li HZ, Wang Y, Gao Y et al (2008) Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6(Suppl 6):917\u2013928","journal-title":"Mol Cancer Res"},{"issue":"Suppl 2","key":"1388_CR46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12032-009-9194-z","volume":"27","author":"J Wang","year":"2010","unstructured":"Wang J, Yang YH, Wang AQ (2010) Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27(Suppl 2):219\u2013223","journal-title":"Med Oncol"},{"issue":"Suppl 4","key":"1388_CR47","first-page":"1208","volume":"131","author":"HC Lee","year":"2006","unstructured":"Lee HC, Tian B, Sedivy JM, Wands JR, Kim M (2006) Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 131(Suppl 4):1208\u20131217","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"1388_CR48","first-page":"229","volume":"39","author":"CJ Hu","year":"2011","unstructured":"Hu CJ, Zhou L, Zhang J, Huang C, Zhang GM (2011) Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. J Int Med Res 39(Suppl 1):229\u2013237","journal-title":"J Int Med Res"},{"issue":"Suppl 5","key":"1388_CR49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.prp.2012.02.011","volume":"208","author":"HS Kim","year":"2012","unstructured":"Kim HS, Won KY, Kim GY et al (2012) Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma. Pathol Res Pract 208(Suppl 5):292\u2013299","journal-title":"Pathol Res Pract"},{"issue":"Suppl 1","key":"1388_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00428-011-1174-y","volume":"460","author":"HS Kim","year":"2012","unstructured":"Kim HS, Lee SH, Won KY (2012) Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater. Virchows Arch 460(Suppl 1):61\u201368","journal-title":"Virchows Arch"},{"key":"1388_CR51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pros.20319","volume":"66","author":"Z Fu","year":"2006","unstructured":"Fu Z, Kitagawa Y, Shen R et al (2006) Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 66:248\u2013256","journal-title":"Prostate"},{"issue":"Suppl 10","key":"1388_CR52","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1158\/1078-0432.CCR-07-4496","volume":"14","author":"D Chatterjee","year":"2008","unstructured":"Chatterjee D, Sabo E, Tavares R, Resnick MB (2008) Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 14(Suppl 10):2994\u20133001","journal-title":"Clin Cancer Res"},{"issue":"Suppl 2","key":"1388_CR53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12253-011-9470-z","volume":"18","author":"C Gao","year":"2012","unstructured":"Gao C, Pang L, Ren C, Ma T (2012) Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma. Pathol Oncol Res 18(Suppl 2):471\u2013477","journal-title":"Pathol Oncol Res"},{"issue":"Suppl 7","key":"1388_CR54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00313025.2010.522172","volume":"42","author":"HS Kim","year":"2010","unstructured":"Kim HS, Kim GY, Lim SJ, Kim YW (2010) Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma. Pathology 42(Suppl 7):655\u2013660","journal-title":"Pathology"},{"issue":"Suppl 11","key":"1388_CR55","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.humpath.2010.04.012","volume":"41","author":"HS Kim","year":"2010","unstructured":"Kim HS, Kim GY, Lim SJ, Park YK, Kim YW (2010) Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma. Hum Pathol 41(Suppl 11):1609\u20131616","journal-title":"Hum Pathol"},{"issue":"Suppl 17","key":"1388_CR56","doi-asserted-by":"crossref","first-page":"17515","DOI":"10.1074\/jbc.M313816200","volume":"279","author":"D Chatterjee","year":"2004","unstructured":"Chatterjee D, Bai Y, Wang Z et al (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279(Suppl 17):17515\u201317523","journal-title":"J Biol Chem"},{"issue":"Suppl 4","key":"1388_CR57","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jcb.22611","volume":"110","author":"L Ruan","year":"2010","unstructured":"Ruan L, Wang GL, Yi H, Chen Y et al (2010) Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110(Suppl 4):975\u2013981","journal-title":"J Cell Biochem"},{"issue":"Suppl 1","key":"1388_CR58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2008.04.072","volume":"72","author":"KM Woods Ignatoski","year":"2008","unstructured":"Woods Ignatoski KM, Grewal NK, Markwart SM et al (2008) Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. Int J Radiat Oncol Biol Phys 72(Suppl 1):153\u2013160","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 4","key":"1388_CR59","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/jcp.2007.046987","volume":"61","author":"F Al-Mulla","year":"2008","unstructured":"Al-Mulla F, Hagan S, Al-Ali W (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61(Suppl 4):524\u2013529","journal-title":"J Clin Pathol"},{"issue":"Suppl 10","key":"1388_CR60","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/gut.2005.082859","volume":"55","author":"P Minoo","year":"2006","unstructured":"Minoo P, Baker K, Goswami R (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55(Suppl 10):1467\u20131474","journal-title":"Gut"},{"issue":"12","key":"1388_CR61","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1158\/0008-5472.CAN-11-3546","volume":"72","author":"G Ren","year":"2012","unstructured":"Ren G, Baritaki S, Marathe H et al (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72(12):3091\u20133104","journal-title":"Cancer Res"},{"issue":"1","key":"1388_CR62","doi-asserted-by":"crossref","first-page":"e29532","DOI":"10.1371\/journal.pone.0029532","volume":"7","author":"F Al-Mulla","year":"2012","unstructured":"Al-Mulla F, Bitar MS, Feng J, Park S, Yeung KC (2012) A new model for raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One 7(1):e29532","journal-title":"PLoS One"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1388-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1388-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:36:08Z","timestamp":1559064968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1388-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1388"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1388-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]}}}